Benzoates
Research News and Information

Sunday, March 21, 2010

Nitric oxide potentiation of locomotor activity in the spinal cord of the lamprey.

19 Oct 2009 To understand the intrinsic operation of spinal networks generating locomotion, we need to not only characterize the constituent neurons and their connectivity, but also determine the role of intrinsic modulation in shaping the final motor output. ... Read more...

Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease.

19 Sep 2009 BACKGROUND: Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers reduce left ventricular hypertrophy (LVH). The effect of these drugs on LVH in high-risk patients without heart failure is unknown. METHODS AND RESULTS: In ... Read more...

Lessons learned from the ONTARGET and TRANSCEND trials.

30 Aug 2009 Cardiovascular disease (CVD) accounts for one of every three deaths in the United States. In recent years, a greater understanding of the renin-angiotensin-aldosterone system's (RAAS) contribution to CVD, particularly in the area of blood pressure ... Read more...

Latest indexed articles for 'Benzoates'

These are the very latest articles for this heading:

• Nitric oxide potentiation of locomotor activity in the spinal cord of the lamprey. 19 Oct 2009
• Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease. 19 Sep 2009
• Lessons learned from the ONTARGET and TRANSCEND trials. 30 Aug 2009
• Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial. 30 Aug 2009
• The protective role of telmisartan against nephrotoxicity induced by X-ray contrast media in rat model. 30 Aug 2009
• Cerebroprotective action of telmisartan by inhibition of macrophages/microglia expressing HMGB1 via a peroxisome proliferator-activated receptor gamma-dependent mechanism. 19 Aug 2009
• [Erectile dysfunction as a harbinger of cardiovascular events. Long-term vascular protection with telmisartan] 18 Aug 2009
• Chronic treatment with losartan results in sufficient serum levels of the metabolite EXP3179 for PPARgamma activation. 15 Aug 2009
• [Treatment of scabies in Senegal] 11 Aug 2009
• Behavioural profile of selective ligands for mGlu7 and mGlu8 glutamate receptors in agonistic encounters between mice. 30 Jul 2009
• Proteinuria: Is the ONTARGET renal substudy actually off target? 30 Jul 2009
• Concerted proton-electron transfer in a ruthenium terpyridyl-benzoate system with a large separation between the redox and basic sites. 27 Jul 2009
• Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation. 25 Jul 2009
• Structure-activity analysis of 2'-modified cinnamaldehyde analogues as potential anticancer agents. 23 Jul 2009
• Clinical images: Infestation by Norwegian scabies. 18 Jul 2009
• Benzoate catabolite repression of the phenol degradation in Acinetobacter calcoaceticus PHEA-2. 12 Jul 2009
• Treatment of dermatophytosis in young cattle with propolis and Whitfield's ointment. 9 Jul 2009
• Lipid extraction and determination of halogenated phenols and alkylphenols as their pentafluorobenzoyl derivatives in marine organisms. 6 Jul 2009
• AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats. 5 Jul 2009
• Synthesis and evaluation of radamide analogues, a chimera of radicicol and geldanamycin. Jul 2009

See a longer list of these articles.

Technical information about 'Benzoates'

Definition: Salts and esters of BENZOIC ACID that possess antibacterial and antifungal properties. They are used as preservatives in pharmaceuticals, cosmetics, and foods.

Registry Number: 0

Descriptor UI: D001565

Alternative terms: Benzoates; Potassium Benzoate; Benzoate, Potassium; Benzoate;

Related Mesh Headings: Chalcone;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Pharmacological Action: Antifungal Agents; Anti-Infective Agents;

Tree Number: D02.241.223.100.140.100;

History Note: 1963; for BENZOATE & POTASSIUM BENZOATE use BENZOIC ACID (NM) 1980-98